** Sino Biopharmaceutical 1177.HK rises 4.3% to HK$3.41; set for biggest one-day pct gain since Oct. 18
** Co buys 4.91% stake in LaNova Medicines for 142 mln yuan ($19.6 mln), enters into agreement for LM-108, a monoclonal antibody for various solid tumour treatment currently at Phase II clinical stage, in Mainland China region
** Says further cooperations with LaNova for various innovative bispecific antibody and antibody-drug conjugates in its pipelines
** Hong Kong's healthcare index .HSCIH up 2.9%
** Stock down 5.8% YTD
($1 = 7.2418 Chinese yuan renminbi)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。